Study for determination of the optimal cessation period of therapy with anti-platelet agents prior to invasive endoscopic procedures
- 2 August 2005
- journal article
- research article
- Published by Springer Nature in The Esophagus
- Vol. 40 (7), 698-707
- https://doi.org/10.1007/s00535-005-1613-0
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Antiplatelet TherapyCirculation, 2003
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- Thienopyridines or Aspirin to Prevent Stroke and Other Serious Vascular Events in Patients at High Risk of Vascular Disease?Stroke, 2000
- Preventing Ischemic Stroke in Patients With Prior Stroke and Transient Ischemic AttackStroke, 1999
- Guideline on the management of anticoagulation and antiplatelet therapy for endoscopic proceduresGastrointestinal Endoscopy, 1998
- The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic strokeThe Lancet, 1997
- Gastrointestinal endoscopy in patients taking antiplatelet agents and anticoagulants: survey of ASGE membersGastrointestinal Endoscopy, 1996
- Risk of bleeding after endoscopic biopsy or polypectomy in patients taking aspirin or other NSAIDsGastrointestinal Endoscopy, 1994
- A Randomized Trial Comparing Ticlopidine Hydrochloride with Aspirin for the Prevention of Stroke in High-Risk PatientsNew England Journal of Medicine, 1989
- Secondary prevention of vascular disease by prolonged antiplatelet treatmentBMJ, 1988